What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Epilepsy
- Psychiatry
His primary areas of study are Neuroscience, Transcranial magnetic stimulation, Motor cortex, Epilepsy and Stimulation.
His work on Silent period and Inhibitory postsynaptic potential as part of general Neuroscience research is frequently linked to Chemistry, thereby connecting diverse disciplines of science.
His Motor cortex research integrates issues from Electromyography and Cerebral hemisphere.
The study incorporates disciplines such as Stroke, Internal medicine and Somatosensory system in addition to Electromyography.
Konrad J. Werhahn combines subjects such as Concomitant, Anesthesia and Statistical significance with his study of Epilepsy.
Konrad J. Werhahn has researched Stimulation in several fields, including Evoked potential and Central nervous system disease.
His most cited work include:
- Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans (718 citations)
- The effect of magnetic coil orientation on the latency of surface EMG and single motor unit responses in the first dorsal interosseous muscle (300 citations)
- Transcranial magnetic stimulation for the treatment of seizures: a controlled study. (224 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Epilepsy, Neuroscience, Anesthesia, Internal medicine and Motor cortex.
His Epilepsy research is multidisciplinary, incorporating elements of Surgery and Electroencephalography.
His study on Transcranial magnetic stimulation, Stimulation, Silent period and Cortex is often connected to Chemistry as part of broader study in Neuroscience.
He interconnects Somatosensory system, Frontal lobe, Sensory system, Levetiracetam and Pediatrics in the investigation of issues within Anesthesia.
His research in Internal medicine intersects with topics in Carbamazepine, Lacosamide and Cardiology.
His Motor cortex research includes elements of Electromyography and Cerebral hemisphere.
He most often published in these fields:
- Epilepsy (47.62%)
- Neuroscience (28.57%)
- Anesthesia (28.57%)
What were the highlights of his more recent work (between 2013-2020)?
- Epilepsy (47.62%)
- Internal medicine (25.00%)
- Lacosamide (13.10%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Epilepsy, Internal medicine, Lacosamide, Anesthesia and Adverse effect.
The various areas that Konrad J. Werhahn examines in his Epilepsy study include Body mass index, Vigilance, Neuropsychology, Stroke and Pediatrics.
His Pediatrics research includes themes of Executive functions, Cognition, Physical therapy, Etiology and Comorbidity.
His study in Internal medicine is interdisciplinary in nature, drawing from both Carbamazepine and Levetiracetam.
His biological study spans a wide range of topics, including Adjunctive treatment and Seizure frequency.
His studies in Anesthesia integrate themes in fields like Hippocampus, Neuroscience, Putamen, Confidence interval and Ictal.
Between 2013 and 2020, his most popular works were:
- Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial. (139 citations)
- A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy. (91 citations)
- Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial (65 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Epilepsy
- Psychiatry
Konrad J. Werhahn mostly deals with Epilepsy, Anesthesia, Tolerability, Internal medicine and Levetiracetam.
The Epilepsy study combines topics in areas such as Executive functions, Cognition, Physical therapy, Pediatrics and Comorbidity.
The concepts of his Anesthesia study are interwoven with issues in Gastroenterology, Carbamazepine and Brivaracetam.
His study brings together the fields of Adverse effect and Carbamazepine.
His Adverse effect research is multidisciplinary, incorporating perspectives in Young adult, Randomized controlled trial, Lacosamide and Clinical trial.
His work deals with themes such as Concomitant, Discontinuation, Statistical significance and Seizure types, which intersect with Levetiracetam.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
